Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 2/20 | 0.39 |
| ▸ | PARP1 | P09874 | 2/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | S100A4 | P26447 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | TDP2 | O95551 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9468595 | 0.85 | CYP3A4 (0.40) | CYP3A4TDP1POLBBCHEACHE | |
| SCHEMBL29260787 | 0.85 | CYP3A4 (0.39) | CYP3A4TDP1POLBBCHEACHE | |
| SCHEMBL8092353 | 0.81 | ALDH1A1 (0.55) | CYP3A4TDP1POLBSMN1; SMN2MEN1 | |
| SCHEMBL28138230 | 0.81 | CYP3A4 (0.46) | CYP3A4TDP1POLBSMN1; SMN2MEN1 | |
| SCHEMBL28133852 | 0.81 | CYP3A4 (0.46) | CYP3A4TDP1POLBBCHEACHE | |
| SCHEMBL8098610 | 0.81 | TDP1 (0.46) | CYP3A4TDP1POLBBCHEACHE | |
| SCHEMBL19358248 | 0.81 | CYP3A4 (0.46) | CYP3A4TDP1POLBBCHEACHE | |
| SCHEMBL768176 | 0.81 | TDP1 (0.46) | CYP3A4TDP1POLBBCHEACHE | |
| SCHEMBL28061763 | 0.81 | TDP1 (0.47) | CYP3A4TDP1POLBBCHEACHE | |
| SCHEMBL5151002 | 0.78 | POLB (0.44) | CYP3A4TDP1POLBSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271901-A | Alcohol-soluble environment-friendly printing ink and preparation method thereof | 厦门欧化实业有限公司 | 2024-07-02 | — | — | CN | claimed |
| US-20190153160-A1 | POLYETHERIMIDE COMPOSITIONS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2019-05-23 | — | — | US | claimed |
| JP-60097647-A | — | — | None | — | — | JP | disclosed |
| JP-59170119-A | — | — | None | — | — | JP | disclosed |
| CN-118271901-A | Alcohol-soluble environment-friendly printing ink and preparation method thereof | 厦门欧化实业有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-20190153160-A1 | POLYETHERIMIDE COMPOSITIONS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2019-05-23 | — | — | US | disclosed |
| US-10227452-B2 | Polyetherimide compositions and methods for the manufacture and use thereof | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-03-12 | — | — | US | disclosed |
| US-20170260333-A1 | POLYETHERIMIDE COMPOSITIONS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2017-09-14 | — | — | US | disclosed |
| US-9688816-B2 | Polyetherimide compositions and methods for the manufacture and use thereof | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-27 | — | — | US | disclosed |
| US-20170087129-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASES WITH PDE4 MODULATORS | NEW YORK UNIVERSITY | 2017-03-30 | — | — | US | disclosed |
| US-20150133625-A1 | POLYETHERIMIDE COMPOSITIONS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2015-05-14 | — | — | US | disclosed |
| US-5120824-A | Molding materials based on unsaturated monomers containing imide groups; engineering thermoplastics; toughness; heat resistance | TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) | 1992-06-09 | — | — | US | disclosed |
| EP-0375079-A2 | Alkenylphoxylimide modified polyimide | Technochemie GmbH - Verfahrenstechnik (DE) | 1990-06-27 | — | — | EP | disclosed |
| US-4870124-A | POLYESTER AND HYDROGENATED ALPHA-OLEFIN OLIGOMER AS RELEASE AGENT | GENERAL ELECTRIC COMPANY (US) | 1989-09-26 | — | — | US | disclosed |
| US-4870123-A | POLYPHENYLENE ETHER AND HYDROGENATED ALPHA-OLEFIN OLIGOMER AS RELEASE AGENT | GENERAL ELECTRIC COMPANY (US) | 1989-09-26 | — | — | US | disclosed |
| US-4870125-A | THERMOPLASTIC POLYETHERIMIDE AND HYDROGENATED ALPHA-OLEFIN OLIGOMER RELEASE AGENT | GENERAL ELECTRIC COMPANY (US) | 1989-09-26 | — | — | US | disclosed |
| EP-0321707-A2 | Thermoplastic resin composition containing mould release agents | GENERAL ELECTRIC COMPANY (US) | 1989-06-28 | — | — | EP | disclosed |
| US-4826913-A | POLYARYL SULFONE AND HYDROGENATED OLIGOMER RELEASE AGENT | GENERAL ELECTRIC COMPANY (US) | 1989-05-02 | — | — | US | disclosed |
| JP-S6097647-A | SEMICONDUCTOR DEVICE | HITACHI LTD | 1985-05-31 | — | — | JP | disclosed |
| JP-S59170119-A | PREPARATION OF THERMOPLASTIC POLYETHER IMIDE POYMER | HITACHI CHEM CO LTD | 1984-09-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170087129-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASES WITH PDE4 MODULATORS | PDE4A, PDE4B, PDE3B | CYP3A4 608/4885TDP1 160/4885POLB 1008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.